Email

daphne.medina@bcm.edu

Positions

Research Coordinator I

Pediatrics - Nutrition
Baylor College of Medicine

Education

BSc from University of Houston - Clear Lake

12/2023 - Houston, Texas United States

Bioanalytical Chemistry, Human Biology

Certifications

Certified Pharmacy Technician

#E7P5L8E8 (05/24/2019 - 05/24/2025)

National Health Association

Projects

Genetic Disorders of Obesity Program (CGDO)

(04/2021 - present)

This project is for collecting information on all children who come into the CGDO clinic. The aim is to use this information to determine better strategies for identifying children who would benefit from genetic testing, how children respond to therapies, and how to better support parents. This project also includes collecting cheek swabs of children and their parents for genetic analysis by future studies.

etmelanotide Phase 2 and Phase 3 Treatment Trials in Patients with Rare Genetic Disorders of Obesity

(08/2020 - present)

This project is several clinical trials that have a purpose to determine the effect of setmelanotide (RM-493) on weight, hunger assessments, and other factors in patients with rare genetic disorders of obesity. • RM-493-014; Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients with Rare Genetic Disorders of Obesity (currently closed for enrollment) • RM-493-022; Long-Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated with Genetic Defects Upstream of the MC4 Receptor in the Leptin-Melanocortin Pathway (open) • RM-4930-034; A 2-Stage (Open-Label Run-in followed by Randomized Withdrawal), Double-Blind, Placebo-Controlled, Phase 2 Study of Setmelanotide in Patients with Specific Gene Defects in the Melanocortin-4 Receptor Pathway (will open soon) • RM-493-035; A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study: 5 Independent Sub-studies of Setmelanotide in Patients with POMC, PCSK1, LEPR, SRC1, SH2B1, and PCSK1 N221D Gene Defects in the Melanocortin-4 Receptor Pathway (will open soon)

Languages

Spanish